UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034431
Receipt number R000038884
Scientific Title Effects of Blind Makeup Application in Persons with Impaired Vision: Brain Activity Evaluation by Functional Magnetic Resonance Imaging
Date of disclosure of the study information 2018/10/10
Last modified on 2024/04/16 10:27:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Blind Makeup Application in Persons with Impaired Vision: Brain Activity Evaluation by Functional Magnetic Resonance Imaging

Acronym

Effects of Blind Makeup Application in Persons with Impaired Vision: Brain Activity Evaluation by Functional Magnetic Resonance Imaging

Scientific Title

Effects of Blind Makeup Application in Persons with Impaired Vision: Brain Activity Evaluation by Functional Magnetic Resonance Imaging

Scientific Title:Acronym

Effects of Blind Makeup Application in Persons with Impaired Vision: Brain Activity Evaluation by Functional Magnetic Resonance Imaging

Region

Japan


Condition

Condition

Persons with Impaired Vision

Classification by specialty

Psychiatry Radiology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to verify the effect of the visually impaired person's make-up (blind makeup) on brain activity using functional magnetic resonance imaging (fMRI).

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

fMRI measurement
(1)Measurement device
An Ingenia 3.0T (manufactured by Philips) will be used.
(2)Measurement methods
(i)Advance screening
A T2-weighted image will be obtained before the fMRI measurement to check that there is no organic disease such as cerebrovascular impairment in the cranium.
(ii)Measurements will be taken when the subject has no facial makeup
A facial cleanser (NOV III Cleansing Cream, NOV III Washing Cream) will be used to wash the face, and then a moisturizing agent (NOV III Face Lotion R) will be applied to eliminate any skin discomfort such as the sensation of dry skin. fMRI measurement will be performed 5 minutes later.
iii) Measurements will be taken while the subject imagines makeup
The radiological technician shall instruct the subject to imagine makeup tasks and will perform the measurement once the subject has done so.
iv)Measurements will be taken after applying makeup
The subject will step down from the measurement stand and apply makeup. Measurements shall be performed immediately after makeup is applied.
(3)Measurement conditions
The previously mentioned 3TMRI scanner will be used for imaging.The functional image will be obtained by gradient echo planar imaging (EPI), and the following parameters are to be set:repetition time (TR) = 3000 ms, echo time (TE) = 30 ms, flip angle = 90, matrix size = 94*94,field of view = 230 mm,size number = 45,slice thickness = 3 mm, interslice gap = 0 mm, acquisition time = 5:09 s.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

A preliminary test will be conducted in 6 right-handed women with normal vision. (1) After washing the face (natural face), the stimuli of (2) makeup activity through recollection and (3) actual makeup application will be induced, fMRI will be performed, and changes in brain function activity will be verified. A blindfold will be worn to eliminate visual stimuli. The strength and time of the stimuli and the brain regions where changes are expected are to be confirmed.

Interventions/Control_2

A main test will be conducted in 6 right-handed women with impaired vision. (1) After washing the face (natural face), the stimuli of (2) makeup activity through recollection and (3) actual makeup application will be induced, fMRI will be performed, and changes in brain function activity will be verified. A blindfold will be worn in the same manner as the preliminary test. The strength and time of the stimuli and the brain regions where changes are expected are to be confirmed.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

- Women who use makeup daily
- Subjects who are right-handed
Persons who provide written consent (oral in the case of persons with vision impairment) of their own volition after receiving a sufficient explanation regarding participating in the study and sufficiently understanding that explanation. Note that if a subject has a disease other than a skin disease, treatment will not be restricted.

Key exclusion criteria

- Persons with severe skin disease on the face
- Persons who have experienced skin symptoms such as contact dermatitis from the ingredients of the study drug or a similar ingredient
- Persons who should avoid fMRI measurements (such as persons with implanted gold thread from cosmetic surgery)
- Persons who use drugs that affect brain activity
- Pregnant women
- Other persons that the investigator deems unsuited to participate in this study

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Toshihide
Middle name
Last name Ogawa

Organization

Kurashiki Heisei Hospital

Division name

Neuroradiology Center

Zip code

710-0826

Address

4-3-38 Oimatsucho Kurashiki, Okayama, 710-0826, japan

TEL

086-427-1111

Email

ogawa@heisei.or.jp


Public contact

Name of contact person

1st name Hiroshi
Middle name
Last name Matsunaka

Organization

TOKIWA Phormaceutical Co., Ltd.

Division name

NOV Academic Research

Zip code

107-0062

Address

1-2-6 Minami-aoyama, Minato-ku, Tokyo 170-0062,Japan

TEL

03-6634-5181

Homepage URL


Email

yumi_murakami@n1.noevir.co.jp


Sponsor or person

Institute

Kurashiki Heisei Hospital

Institute

Department

Personal name



Funding Source

Organization

TOKIWA Phormaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kurashiki Heisei Hospital Certified Review Board

Address

4-3-38 Oimatsucho Kurashiki, Okayama, 710-0826, japan

Tel

086-427-1111

Email

jinji2@heisei.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 10 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Suspended

Date of protocol fixation

2018 Year 10 Month 01 Day

Date of IRB

2018 Year 10 Month 01 Day

Anticipated trial start date

2019 Year 06 Month 01 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 10 Month 10 Day

Last modified on

2024 Year 04 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038884


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name